Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Asaf Danziger. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Asaf Danziger har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:NVCR / NovoCure Limited | Director | 416 474 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Asaf Danziger. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Asaf Danziger som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-08 |
|
5 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 1 | 416 474 | 0,00 | 10,99 | 11 | 4 577 049 | |
| 2025-07-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 833 | 416 473 | 0,20 | 15,13 | 12 603 | 6 301 236 | |
| 2025-01-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 400 000 | 415 640 | 2 557,54 | ||||
| 2025-01-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 412 | 15 640 | 2,71 | 14,75 | 6 076 | 230 659 | |
| 2024-08-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 1 239 | 15 228 | 8,86 | 12,24 | 15 165 | 186 391 | |
| 2023-07-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 367 | 13 989 | 2,69 | 35,28 | 12 948 | 493 532 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 39 | 13 622 | 0,29 | 62,30 | 2 430 | 848 719 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −187 500 | 13 583 | −93,25 | 108,00 | −20 250 000 | 1 466 964 |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 187 500 | 201 083 | 1 380,40 | 7,15 | 1 340 625 | 1 437 743 |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −500 | 13 583 | −3,55 | 119,99 | −59 994 | 1 629 783 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 344 | 14 083 | −8,71 | 119,35 | −160 405 | 1 680 796 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −2 123 | 15 427 | −12,10 | 118,47 | −251 515 | 1 827 658 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −999 | 17 550 | −5,39 | 117,01 | −116 894 | 2 053 545 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 395 | 18 549 | −6,99 | 116,06 | −161 906 | 2 152 830 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −3 702 | 19 944 | −15,66 | 115,21 | −426 512 | 2 297 774 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −4 568 | 23 646 | −16,19 | 114,35 | −522 362 | 2 703 977 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −2 000 | 28 214 | −6,62 | 112,86 | −225 726 | 3 184 322 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −8 369 | 30 214 | −21,69 | 111,23 | −930 916 | 3 360 818 | |
| 2023-01-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 25 000 | 38 583 | 184,05 | 11,46 | 286 500 | 442 161 |
| 2022-07-07 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 276 | 13 583 | 2,07 | 59,08 | 16 305 | 802 416 | |
| 2022-03-07 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 13 470 | 13 470 | 80,59 | 1 085 547 | 1 085 547 | ||
| 2022-01-12 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 31 | 13 307 | 0,23 | 63,82 | 1 978 | 849 226 | |
| 2021-11-29 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
P - Purchase | 104 | 13 276 | 0,79 | 96,50 | 10 036 | 1 281 134 | |
| 2021-11-29 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
P - Purchase | 1 000 | 13 172 | 8,22 | 103,37 | 103 370 | 1 361 590 | |
| 2021-11-29 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
P - Purchase | 3 870 | 12 172 | 46,62 | 102,36 | 396 133 | 1 245 926 | |
| 2021-07-08 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 118 | 8 302 | 1,44 | 137,12 | 16 180 | 1 138 387 | |
| 2021-04-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −97 973 | 8 184 | −92,29 | 196,34 | −19 236 323 | 1 606 872 |
| 2021-03-02 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | −9 259 | 0 | −100,00 | ||||
| 2021-03-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 9 259 | 206 944 | 4,68 | 149,10 | 1 380 517 | 30 855 350 | |
| 2021-01-08 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 53 | 197 685 | 0,03 | 50,67 | 2 685 | 10 016 501 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −103 955 | 0 | −100,00 | ||||
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −103 955 | 0 | −100,00 | ||||
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −400 | 197 632 | −0,20 | 166,08 | −66 432 | 32 822 525 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −971 | 198 032 | −0,49 | 164,96 | −160 175 | 32 667 161 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −536 | 199 003 | −0,27 | 163,35 | −87 555 | 32 506 742 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 700 | 199 539 | −0,84 | 162,35 | −276 000 | 32 395 755 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −4 014 | 201 239 | −1,96 | 161,11 | −646 679 | 32 420 810 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −11 686 | 205 253 | −5,39 | 160,27 | −1 872 915 | 32 895 898 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −4 790 | 216 939 | −2,16 | 159,27 | −762 903 | 34 551 875 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −10 077 | 221 729 | −4,35 | 158,06 | −1 592 811 | 35 047 373 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −23 601 | 231 806 | −9,24 | 157,01 | −3 705 522 | 36 395 165 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −24 973 | 255 407 | −8,91 | 156,08 | −3 897 861 | 39 864 691 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −21 207 | 280 380 | −7,03 | 155,23 | −3 292 005 | 43 523 948 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 103 955 | 301 587 | 52,60 | 22,00 | 2 287 010 | 6 634 914 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 103 955 | 301 587 | 52,60 | 22,00 | 2 287 010 | 6 634 914 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −200 | 197 632 | −0,10 | 166,17 | −33 234 | 32 840 905 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −700 | 197 832 | −0,35 | 165,38 | −115 768 | 32 718 050 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −500 | 198 532 | −0,25 | 164,11 | −82 054 | 32 580 888 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 300 | 199 032 | −0,65 | 162,97 | −211 860 | 32 436 046 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 426 | 200 332 | −0,71 | 162,17 | −231 259 | 32 488 441 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −3 500 | 201 758 | −1,71 | 160,99 | −563 479 | 32 481 827 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −12 092 | 205 258 | −5,56 | 160,25 | −1 937 743 | 32 892 594 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −4 500 | 217 350 | −2,03 | 159,32 | −716 954 | 34 628 854 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −9 183 | 221 850 | −3,97 | 158,09 | −1 451 777 | 35 073 154 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −24 656 | 231 033 | −9,64 | 157,04 | −3 871 904 | 36 280 729 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −24 286 | 255 689 | −8,67 | 156,09 | −3 790 826 | 39 910 752 | |
| 2020-12-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −21 612 | 279 975 | −7,17 | 155,24 | −3 355 047 | 43 463 319 | |
| 2020-09-17 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −103 000 | 207 910 | −33,13 | ||||
| 2020-09-17 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −103 000 | 197 632 | −34,26 | 99,00 | −10 197 000 | 19 565 568 |
| 2020-09-17 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 103 000 | 300 632 | 52,12 | 22,00 | 2 266 000 | 6 613 904 | |
| 2020-07-08 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 284 | 197 632 | 0,14 | 50,40 | 14 315 | 9 961 641 | |
| 2020-03-02 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | −9 259 | 9 259 | −50,00 | ||||
| 2020-03-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 9 259 | 197 348 | 4,92 | 79,45 | 735 628 | 15 679 299 | |
| 2020-02-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | 53 333 | 0 | −100,00 | ||||
| 2020-02-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Share Units |
M - Exercise | 53 333 | 188 089 | 39,58 | 88,26 | 4 707 171 | 16 600 735 | |
| 2020-01-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 155 | 134 756 | 0,12 | 52,58 | 8 150 | 7 085 605 | |
| 2019-11-26 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −103 000 | 310 910 | −24,88 | ||||
| 2019-11-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −103 000 | 134 601 | −43,35 | 95,00 | −9 785 000 | 12 787 095 |
| 2019-11-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 103 000 | 237 601 | 76,52 | 22,00 | 2 266 000 | 5 227 222 |
| 2019-09-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −500 | 134 601 | −0,37 | 92,00 | −46 000 | 12 383 292 | |
| 2019-09-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −65 768 | 135 101 | −32,74 | 91,60 | −6 024 612 | 12 375 792 | |
| 2019-09-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −57 913 | 200 869 | −22,38 | 90,58 | −5 245 586 | 18 194 111 | |
| 2019-07-09 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 471 | 258 782 | 0,18 | 27,81 | 13 099 | 7 197 245 | |
| 2019-07-02 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −187 500 | 187 500 | −50,00 | ||||
| 2019-07-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −187 500 | 258 311 | −42,06 | 62,15 | −11 653 125 | 16 054 029 |
| 2019-07-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 187 500 | 445 811 | 72,59 | 7,15 | 1 340 625 | 3 187 549 |
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −25 000 | 25 000 | −50,00 | ||||
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −25 000 | 258 311 | −8,82 | 61,46 | −1 536 500 | 15 875 794 |
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 25 000 | 283 311 | 9,68 | 11,46 | 286 500 | 3 246 744 |
| 2019-06-19 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −190 338 | 0 | −100,00 | ||||
| 2019-06-19 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −190 338 | 258 311 | −42,42 | 59,37 | −11 300 367 | 15 335 924 |
| 2019-06-19 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 190 338 | 448 649 | 73,69 | 14,37 | 2 735 157 | 6 447 086 |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −30 436 | 190 338 | −13,79 | ||||
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −18 203 | 258 311 | −6,58 | 55,74 | −1 014 544 | 14 396 964 | |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −12 233 | 276 514 | −4,24 | 54,89 | −671 420 | 15 176 747 | |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 30 436 | 288 747 | 11,78 | 14,37 | 437 365 | 4 149 294 |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −16 835 | 220 774 | −7,09 | ||||
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −850 | 258 311 | −0,33 | 55,42 | −47 111 | 14 316 887 | |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −15 985 | 259 161 | −5,81 | 54,71 | −874 539 | 14 178 698 | |
| 2019-06-13 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 16 835 | 275 146 | 6,52 | 14,37 | 241 919 | 3 953 848 |
| 2019-05-10 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 35 000 | 35 000 | |||||
| 2019-05-10 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 115 060 | 115 060 | |||||
| 2019-03-26 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 44 953 | 44 953 | |||||
| 2019-03-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Share Units |
A - Award | 24 554 | 258 311 | 10,50 | ||||
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −16 268 | 237 609 | −6,41 | ||||
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −6 441 | 233 757 | −2,68 | 56,51 | −363 994 | 13 210 076 | |
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −6 127 | 240 198 | −2,49 | 56,00 | −343 124 | 13 451 568 | |
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −3 700 | 246 325 | −1,48 | 54,64 | −202 168 | 13 459 198 | |
| 2019-03-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 16 268 | 250 025 | 6,96 | 14,37 | 233 771 | 3 592 859 |
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −100 000 | 253 877 | −28,26 | ||||
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −6 903 | 233 757 | −2,87 | 56,49 | −389 923 | 13 203 998 | |
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −55 815 | 240 660 | −18,83 | 55,85 | −3 117 156 | 13 440 380 | |
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −37 282 | 296 475 | −11,17 | 54,97 | −2 049 503 | 16 298 120 | |
| 2019-03-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 100 000 | 333 757 | 42,78 | 14,37 | 1 437 000 | 4 796 088 |
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −903 | 353 887 | −0,25 | ||||
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −903 | 233 757 | −0,38 | 54,40 | −49 119 | 12 715 212 | |
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 903 | 234 660 | 0,39 | 14,37 | 12 976 | 3 372 064 |
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | −9 260 | 18 518 | −33,34 | ||||
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 9 260 | 233 757 | 4,12 | 52,90 | 489 854 | 12 365 745 | |
| 2019-02-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | −53 333 | 53 333 | −50,00 | ||||
| 2019-02-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 53 333 | 224 497 | 31,16 | 53,38 | 2 846 916 | 11 983 650 | |
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −17 902 | 50 000 | −26,36 | ||||
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −17 902 | 171 164 | −9,47 | 51,46 | −921 237 | 8 808 099 |
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 17 902 | 189 066 | 10,46 | 11,46 | 205 157 | 2 166 696 |
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −32 098 | 67 902 | −32,10 | ||||
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −32 098 | 171 164 | −15,79 | 51,46 | −1 651 763 | 8 808 099 |
| 2019-02-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 32 098 | 203 262 | 18,75 | 11,46 | 367 843 | 2 329 383 |
| 2019-01-25 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −88 695 | 0 | −100,00 | ||||
| 2019-01-25 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −88 695 | 171 164 | −34,13 | 47,48 | −4 211 239 | 8 126 867 | |
| 2019-01-25 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 88 695 | 259 859 | 51,82 | 7,48 | 663 439 | 1 943 745 |
| 2019-01-22 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −46 863 | 0 | −100,00 | ||||
| 2019-01-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −13 644 | 171 164 | −7,38 | 46,16 | −629 793 | 7 900 759 | |
| 2019-01-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −33 219 | 184 808 | −15,24 | 45,80 | −1 521 563 | 8 464 946 | |
| 2019-01-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 46 863 | 218 027 | 27,38 | 3,44 | 161 209 | 750 013 |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −100 000 | 46 863 | −68,09 | ||||
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −100 000 | 171 164 | −36,88 | 45,26 | −4 526 400 | 7 747 567 | |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 100 000 | 271 164 | 58,42 | 3,44 | 344 000 | 932 804 |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −100 000 | 146 863 | −40,51 | ||||
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 787 | 171 164 | −1,03 | 45,28 | −80 906 | 7 749 450 | |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −98 213 | 172 951 | −36,22 | 45,05 | −4 424 397 | 7 791 270 | |
| 2019-01-18 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 100 000 | 271 164 | 58,42 | 3,44 | 344 000 | 932 804 |
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −100 000 | 246 863 | −28,83 | ||||
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −100 000 | 171 164 | −36,88 | 43,49 | −4 348 800 | 7 443 580 | |
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 100 000 | 271 164 | 58,42 | 3,44 | 344 000 | 932 804 | |
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −100 000 | 346 863 | −22,38 | ||||
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −100 000 | 171 164 | −36,88 | 43,52 | −4 352 400 | 7 449 742 | |
| 2019-01-16 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 100 000 | 271 164 | 58,42 | 3,44 | 344 000 | 932 804 | |
| 2019-01-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 264 | 171 164 | 0,15 | 27,20 | 7 181 | 4 655 661 | |
| 2018-07-10 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 795 | 70 113 | 1,15 | 17,26 | 13 718 | 1 209 800 | |
| 2018-06-29 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −70 364 | 69 318 | −50,37 | 32,09 | −2 257 699 | 2 224 137 |
| 2018-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −8 308 | 139 682 | −5,61 | 32,04 | −266 148 | 4 474 727 | |
| 2018-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −621 | 147 990 | −0,42 | 32,00 | −19 872 | 4 735 680 |
| 2018-06-19 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −22 289 | 148 611 | −13,04 | 32,00 | −713 248 | 4 755 552 |
| 2018-06-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −200 | 170 900 | −0,12 | 32,00 | −6 400 | 5 468 800 |
| 2018-06-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −11 720 | 171 100 | −6,41 | 32,00 | −375 040 | 5 475 200 |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −2 800 | 182 820 | −1,51 | 32,00 | −89 600 | 5 850 240 |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −19 694 | 185 620 | −9,59 | 31,64 | −623 118 | 5 873 017 | |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −28 150 | 205 314 | −12,06 | 30,34 | −854 071 | 6 229 227 | |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −26 782 | 233 464 | −10,29 | 29,31 | −784 980 | 6 842 830 | |
| 2018-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −149 878 | 260 246 | −36,54 | 28,43 | −4 261 032 | 7 398 794 | |
| 2018-03-01 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Unit |
A - Award | 27 778 | 27 778 | |||||
| 2018-03-01 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 202 758 | 202 758 | |||||
| 2018-02-26 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Units |
M - Exercise | 53 334 | 106 666 | 100,00 | ||||
| 2018-02-26 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 53 334 | 410 124 | 14,95 | 21,55 | 1 149 348 | 8 838 172 | |
| 2018-01-31 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −13 974 | 356 790 | −3,77 | 24,02 | −335 588 | 8 568 383 |
| 2018-01-26 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −6 456 | 370 764 | −1,71 | 22,43 | −144 840 | 8 318 053 |
| 2018-01-25 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −10 600 | 377 220 | −2,73 | 22,17 | −235 007 | 8 363 156 |
| 2018-01-25 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −10 248 | 387 820 | −2,57 | 22,03 | −225 794 | 8 544 838 |
| 2018-01-17 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −14 900 | 398 068 | −3,61 | 22,20 | −330 755 | 8 836 433 | |
| 2018-01-16 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −22 895 | 412 968 | −5,25 | 22,02 | −504 237 | 9 095 166 | |
| 2018-01-16 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −313 525 | 435 863 | −41,84 | 22,35 | −7 007 503 | 9 741 843 | |
| 2018-01-10 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
A - Award | 283 | 749 388 | 0,04 | 15,04 | 4 258 | 11 274 542 | |
| 2017-11-08 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −6 919 | 749 105 | −0,92 | 22,00 | −152 218 | 16 480 310 |
| 2017-11-06 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −2 300 | 756 024 | −0,30 | 22,00 | −50 600 | 16 632 528 |
| 2017-11-02 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −15 716 | 758 324 | −2,03 | 22,01 | −345 870 | 16 688 815 | |
| 2017-11-02 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −150 | 774 040 | −0,02 | 22,00 | −3 300 | 17 028 880 |
| 2017-09-27 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −900 | 774 190 | −0,12 | 22,05 | −19 845 | 17 070 890 |
| 2017-09-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −1 772 | 775 090 | −0,23 | 22,00 | −38 984 | 17 051 980 | |
| 2017-09-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −35 500 | 776 862 | −4,37 | 22,01 | −781 518 | 17 102 306 | |
| 2017-07-18 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −354 780 | 0 | −100,00 | ||||
| 2017-07-18 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 354 780 | 812 362 | 77,53 | 0,38 | 134 816 | 308 698 | |
| 2017-07-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 183 | 457 582 | −1,12 | 20,19 | −104 645 | 9 238 581 | |
| 2017-07-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −2 200 | 462 765 | −0,47 | 19,40 | −42 680 | 8 977 641 | |
| 2017-07-11 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −203 900 | 464 965 | −30,48 | 18,08 | −3 685 900 | 8 405 172 | |
| 2017-07-11 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −70 459 | 668 865 | −9,53 | 18,03 | −1 270 658 | 12 062 311 | |
| 2017-07-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 050 | 739 324 | −0,68 | 18,09 | −91 344 | 13 372 893 | |
| 2017-07-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −155 088 | 744 374 | −17,24 | 18,14 | −2 813 917 | 13 505 922 | |
| 2017-07-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
A - Award | 2 545 | 899 462 | 0,28 | 6,67 | 16 983 | 6 002 110 | |
| 2017-06-21 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −124 720 | 896 917 | −12,21 | 15,51 | −1 934 906 | 13 914 770 | |
| 2017-06-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −9 212 | 1 021 637 | −0,89 | 15,02 | −138 346 | 15 342 944 | |
| 2017-06-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −33 245 | 1 030 849 | −3,12 | 15,19 | −504 892 | 15 655 504 | |
| 2017-06-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 402 | 1 064 094 | −0,51 | 15,01 | −81 068 | 15 968 859 | |
| 2017-06-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −88 700 | 1 069 496 | −7,66 | 15,23 | −1 351 078 | 16 290 563 | |
| 2017-06-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 100 | 1 158 196 | −0,44 | 15,08 | −76 934 | 17 471 387 | |
| 2017-06-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −175 501 | 1 163 296 | −13,11 | 15,13 | −2 654 979 | 17 598 342 | |
| 2017-02-28 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −342 954 | 0 | −100,00 | ||||
| 2017-02-28 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 342 954 | 1 338 797 | 34,44 | 0,17 | 58 302 | 227 595 | |
| 2017-02-24 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Unit |
A - Award | 160 000 | 160 000 | |||||
| 2017-02-24 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 375 000 | 375 000 | |||||
| 2017-01-06 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
A - Award | 3 156 | 995 843 | 0,32 | 6,67 | 21 060 | 6 645 260 | |
| 2016-04-14 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −59 130 | 0 | −100,00 | ||||
| 2016-04-14 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 59 130 | 992 687 | 6,33 | 0,17 | 10 052 | 168 757 | |
| 2016-03-04 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
P - Purchase | 10 000 | 933 557 | 1,08 | 15,00 | 150 000 | 14 003 355 | |
| 2016-02-26 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 100 000 | 100 000 | |||||
| 2015-10-05 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 413 910 | 413 910 | |||||
| 2015-10-01 | 3 | NVCR |
Novocure Ltd
Ordinary Shares |
1 847 114 | ||||||||
| 2015-10-01 | 3 | NVCR |
Novocure Ltd
Ordinary Shares |
1 847 114 |